Use of a Genetic Variant Related to Circulating FXa (Activated Factor X) Levels to Proxy the Effect of FXa Inhibition on Cardiovascular Outcomes-MedSci.cn

Use of a Genetic Variant Related to Circulating FXa (Activated Factor X) Levels to Proxy the Effect of FXa Inhibition on Cardiovascular Outcomes

Gill, D; Burgess, S

Gill, D (corresponding author), Imperial Coll London, St Marys Hosp, Sch Publ Hlth, Dept Epidemiol & Biostat, Med Sch Bldg, London W2 1PG, England.

CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2020; 13 (5): 551

科室
- - 订阅+
  - 更多科室
工具
服务